BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23298490)

  • 1. The lack of cytomegalovirus-specific cellular immune response may contribute to the onset of organ infection and disease in lung transplant recipients.
    Costa C; Saldan A; Sinesi F; Sidoti F; Balloco C; Simeone S; Piceghello A; Mantovani S; Di Nauta A; Solidoro P; Cavallo R
    Int J Immunopathol Pharmacol; 2012; 25(4):1003-9. PubMed ID: 23298490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.
    Wiita AP; Roubinian N; Khan Y; Chin-Hong PV; Singer JP; Golden JA; Miller S
    Transpl Infect Dis; 2012 Jun; 14(3):248-58. PubMed ID: 22385394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients.
    Kotsimbos AT; Sinickas V; Glare EM; Esmore DS; Snell GI; Walters EH; Williams TJ
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1241-6. PubMed ID: 9351628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.
    Gerna G; Lilleri D; Furione M; Castiglioni B; Meloni F; Rampino T; Agozzino M; Arbustini E
    New Microbiol; 2012 Jul; 35(3):279-87. PubMed ID: 22842597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.
    Baldanti F; Lilleri D; Campanini G; Comolli G; Ridolfo AL; Rusconi S; Gerna G
    J Antimicrob Chemother; 2004 Mar; 53(3):536-9. PubMed ID: 14739146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis.
    Michaelides A; Liolios L; Glare EM; Spelman DW; Bailey MJ; Walters EH; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2001 Jul; 72(1):141-7. PubMed ID: 11468549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.
    Lilleri D; Gerna G; Bruno F; Draghi P; Gabanti E; Fornara C; Meloni F
    New Microbiol; 2013 Jul; 36(3):267-77. PubMed ID: 23912868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
    San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM;
    Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients.
    Wéclawiak H; Kamar N; Mengelle C; Guitard J; Esposito L; Lavayssière L; Cointault O; Ribes D; Rostaing L
    J Med Virol; 2008 Jul; 80(7):1228-32. PubMed ID: 18461614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
    Bounaadja L; Piret J; Goyette N; Boivin G
    J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.
    Gabanti E; Bruno F; Scaramuzzi L; Mangione F; Zelini P; Gerna G; Lilleri D
    New Microbiol; 2016 Oct; 39(4):247-258. PubMed ID: 27727404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.
    Chiereghin A; Gabrielli L; Zanfi C; Petrisli E; Lauro A; Piccirilli G; Baccolini F; Dazzi A; Cescon M; Morelli MC; Pinna AD; Landini MP; Lazzarotto T
    Transplant Proc; 2010; 42(1):69-73. PubMed ID: 20172283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.
    Weclawiak H; Kamar N; Mengelle C; Esposito L; Mohamed AO; Lavayssiere L; Ribes D; Cointault O; Nogier MB; Cardeau-Desangles I; Izopet J; Rostaing L
    Transpl Int; 2010 Oct; 23(10):1056-64. PubMed ID: 20477997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of interleukin-10 detection in lung transplant patients with human cytomegalovirus infection with respect to virus persistence.
    Zedtwitz-Liebenstein K; Jaksch P; Wulkersdorfer B; Friehs H; Pempelfort SD; Burgmann H; Frass M
    Transplantation; 2007 Jul; 84(2):268-71. PubMed ID: 17667821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation.
    Costa C; Delsedime L; Solidoro P; Curtoni A; Bergallo M; Libertucci D; Baldi S; Rinaldi M; Cavallo R
    Transplant Proc; 2010 May; 42(4):1270-4. PubMed ID: 20534278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.